CHAMPIONS ONCOLOGY, INC. Capital Expenditures Incurred but Not yet Paid
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Capital Expenditures Incurred but Not yet Paid of $125.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-07-31 was $125.00K, a 56.29% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-04-30 was -$97.00K.
- CHAMPIONS ONCOLOGY, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-01-31 was $172.00K, a 59.81% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-10-31 was -$263.00K.
- CHAMPIONS ONCOLOGY, INC. capital expenditures incurred but not yet paid for fiscal 2026 was $98.00K, a 50.25% decline from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $197.00K.
- CHAMPIONS ONCOLOGY, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $0.00.
- CHAMPIONS ONCOLOGY, INC. capital expenditures incurred but not yet paid for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-07-31 | $125.00K 10-Q · filed 2026-09-11 | $28.00K derived: sum of 2 quarters · filed 2026-09-11 | $200.00K derived: sum of 3 quarters · filed 2026-09-11 | -$63.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2026-04-30 | -$97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $75.00K derived: sum of 2 quarters · filed 2026-07-27 | -$188.00K derived: sum of 3 quarters · filed 2026-07-27 | $98.00K 10-K · filed 2026-07-27 |
| 2026-01-31 | $172.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-12 | -$91.00K derived: sum of 2 quarters · filed 2026-03-12 | $195.00K 10-Q · filed 2026-03-12 | -$36.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-10-31 | -$263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | $23.00K 10-Q · filed 2025-12-15 | -$208.00K derived: sum of 3 quarters · filed 2026-09-11 | $220.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-07-31 | $286.00K 10-Q · filed 2026-09-11 | $55.00K derived: sum of 2 quarters · filed 2026-09-11 | $483.00K derived: sum of 3 quarters · filed 2026-09-11 | $483.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-04-30 | -$231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $197.00K derived: sum of 2 quarters · filed 2026-07-27 | $197.00K derived: sum of 3 quarters · filed 2026-07-27 | $197.00K 10-K · filed 2026-07-27 |
| 2025-01-31 | $428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-12 | $428.00K derived: sum of 2 quarters · filed 2026-03-12 | $428.00K 10-Q · filed 2026-03-12 | $428.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | $0.00 10-Q · filed 2025-12-15 | $0.00 derived: sum of 3 quarters · filed 2025-12-15 | |
| 2024-07-31 | $0.00 10-Q · filed 2025-09-15 | $0.00 derived: sum of 2 quarters · filed 2025-09-15 | ||
| 2024-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | $0.00 10-K · filed 2025-07-23 | ||
| 2024-01-31 | $0.00 10-Q · filed 2025-03-17 | |||
| 2021-10-31 | $0.00 10-Q · filed 2021-12-13 | |||
| 2021-04-30 | $0.00 10-K · filed 2021-07-26 | |||
| 2020-10-31 | $240.00K 10-Q · filed 2021-12-13 | |||
| 2020-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | $160.00K 10-K · filed 2021-07-26 | ||
| 2020-01-31 | $160.00K 10-Q · filed 2020-03-16 | |||
| 2019-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | $0.00 10-K · filed 2020-07-28 | ||
| 2019-01-31 | $0.00 10-Q · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |